KAREN LABER: Open Payments
NPI 1144955121 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 17 payments from 8 companies in 2025. Trend: 2023 $828 · 2024 $1,796 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $296 |
| Axsome Therapeutics, Inc. | 5 | $220 |
| Neurocrine BioSciences, Inc. | 2 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $112 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, Auvelity, INGREZZA, CAPLYTA, SPRAVATO, ZURZUVAE, Jornay PM, HETLIOZ.
Industry payments across CO — which companies pay providers there.
